More Gains Ahead For The Biotech ETF (IBB)?

From Dana Lyons: Last fall, we laid out the foundation for the current rally in pharmaceutical and biotech stocks; we take stock of those setups and the sectors’ present prospects.
NASDAQ:IBB June 29, 2017 8:55am

iShares NASDAQ Biotechnology Index ETF (IBB) Suddenly Looks Bullish

It has been some time since we last spoke about the Biotech Equity segment in this piece, as the sector was simply not a solid performer through much of 2016 and has only recently come to life here in mid-2017.
NASDAQ:IBB June 26, 2017 11:50am

Analyst: Buy Biotech (IBB) On The Next Pullback

From David Dutkewych: Three weeks ago, I wrote about money pouring into U.S. stocks, specifically technology stocks. Now, just three weeks later, the high-flying tech sector is writing a different story.
NASDAQ:IBB June 23, 2017 6:51am

What’s Next For Biotech Stocks? (IBB)

From Franklin Templeton Investments: Changing political policies and priorities can impact certain market sectors—for better or worse. Health care costs and prescription drug pricing were hot-button issues in the United States during the 2016 presidential election, and the Trump administration
Read more ›
NASDAQ:IBB June 7, 2017 5:57am

Biotech Firms, NIH Team Up To Stop Trump’s Research Budget Cuts

The CEOs of several prominent biotech companies joined forces with the head of the National Institutes of Health (NIH) today in Washington to try and convince the White House not to seek major budget reductions for medical research.
NASDAQ:IBB May 8, 2017 4:17pm

Will Biotech Bulls Or Bears Blink First?

From Taki Tsaklanos: Stock market indexes gain around 1 percent on Thursday. The small cap index Russell 2000 rose around of 1.15%, making it the best performing U.S. stock market index of the day.
NASDAQ:IBB April 21, 2017 6:21am

BlackRock: Opportunities Abound In Biotech, Healthcare

From BlackRock: A dynamic of haves versus have-nots means that health care is increasingly all about stock picking. Kate Moore sees opportunities in biotech, medical devices, U.S. managed care and selected big pharma with promising drug pipelines.
NASDAQ:IBB April 3, 2017 7:26am

These Sector ETFs Are Looking Pretty Bearish Right Now

From David Fabian: I’m normally an optimistic, “glass-half-full” kind of guy. I roll my eyes every time I see a headline decrying the next market crash or cataclysmic event that will cripple the global economy. I’m quick to discern speculation
Read more ›
NASDAQ:IBB March 23, 2017 6:26am

Have Biotech ETFs Finally Bottomed?

From Zacks: 2016 was a tough year for biotech stocks with the sector facing a lot of criticism for rising drug prices. Although shares did rally post-election in November on hopes that drug pricing would not be a key focus
Read more ›
NASDAQ:IBB March 14, 2017 7:54am

Why The $300 Level Is So Important For The Biotech ETF

biotech stock
From Taki Tsaklanos: Biotechnology stocks are breaking out. They have been consolidating for nearly 20 months. Investors lost interest…and that is exactly what smart investors, in general, want to see in order to buy a market.
NASDAQ:IBB March 3, 2017 6:13am

This Biotech ETF Looks Primed To Rally Again

The biotech sector has gotten a lot of attention lately both in the financial markets and in Washington. The sector, which was one of the worst performing areas of the market in 2016 posting a loss of more than 20%,
Read more ›
NASDAQ:IBB February 20, 2017 6:42am

A Major Recovery Is Brewing In The Biotech & Healthcare Space

From Taki Tsaklanos: Biotechnology was once the darling of stock market investors. Not so anymore, since the summer of 2015 the sector collapsed from 400 points to 250 points in the IBB ETF.
NASDAQ:IBB February 17, 2017 6:33am

Biotech’s Next Big Catalyst Could Be Synthetic DNA

biotech stock
From Jon Markman: It really is a brave new world. Not long ago, a group of prominent scientists announced plans for a project to create synthetic human DNA from scratch.
NASDAQ:IBB February 14, 2017 9:21am

Biotech ETF Recovery Powered By Big Earnings Improvements

From Zacks: The biotech industry, which was shunned by investors last year, made a strong comeback following Trump’s victory in anticipation of softer regulation.
NASDAQ:IBB February 10, 2017 10:49am

Free Investing Ideas Newsletter!

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

From Our Partners

7 Best ETFs for the NEXT Bull Market

Most Popular



Explore More from ETFDailyNews.com

Free Investment Newsletter

Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories